CGT9486-21-202
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Cogent Biosciences, Inc
Start Date
March 1, 2022
End Date
March 31, 2027
Administered By
Duke Cancer Institute
Awarded By
Cogent Biosciences, Inc
Start Date
March 1, 2022
End Date
March 31, 2027